The scaly scalp by Vella Briffa, Dino
Cradle cap
Cradle Cap is the vulgar name for
infantile seborrhoeic eczema. The cause
is unknown. The baby’s scalp becomes
pink and scaly, and greasy yellow crusts
may also form. The rash may spread to
the face and flexures of the ears,
armpits, and groin. Rarely, it could
become generalized, but never
dangerous. The lesions are not itchy,
and they disappear with or without
treatment after a few weeks. The
condition is not infectious, and it does
not lead to adult seborrhoeic eczema2.
The scales of cradlecap can be removed
by rubbing with an emollient, such as
almond oil, followed by a mild
detergent shampoo. Alternatively, 0.5%
salicylic acid in a cream base may be
employed as a mild keratolytic. The
regular use of salicylic acid over a wide
area should be avoided in babies
because it carries the risk of salicylism
due to systemic absorption. Infants
with widespread eczema should be
referred for medical examination. A
prudent pharmacist would not dispense
topical steroids on his/her own
initiative in this type of situation.
Ringworm of the scalp
Ringworm of the scalp is technically
known as tinea capitis. This is an
infection of the scalp hairs by one of a
number of dermatophyte fungi some of
which habitually live on animals or in
the soil, while others spread from one
human being to another in epidemic
fashion. In Malta, the commonest
organism is Microsporum canis,3 which
is a species of animal ringworm
commonly found on stray kittens.
Children are the usual victims. There are
patches of redness, scaling and, most
important, hair loss in the scalp.
Contact with furry animals (kittens,
rabbits, goats), multiple cases in a
family, and concomitant ringworm on
the body are useful aids to diagnosis. A
boggy swelling (kerion) may develop in
neglected or mistreated cases, and this
could lead to permanent hair loss due
to scarring in the area. Tinea capitis
requires careful systemic treatment to
prevent such complications. Suspected
cases should consequently be referred
immediately for specialist care. The use
of topical anti-fungal preparations at
this stage may pre-empt an accurate
mycological diagnosis.
The scaly scalp
A popular atlas of dermatology lists more than 35 diseases
which commonly affect the scalp.1 Scaling is a prominent
feature of several of them. Clearly, a comprehensive review
is not possible within the compass of this article. Instead,
attention will be focused on some relatively common
conditions, which the community pharmacist may be called
upon to recognize and treat. The discussion includes advice
concerning diagnoses, pitfalls, over-the-counter (OTC)
remedies, and when to refer.
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Figure 1: Tinea Capitis (Ducray archives)
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Dandruff and
adult seborrhoeic eczema
Seborrhoeic eczema affects
approximately 5% of adults. It is even
commoner in Parkinson’s disease, and
in HIV/AIDS where it may be the
presenting complaint. Our
understanding of seborrhoeic eczema
turned full circle over the years. In the
19th century Sabouraud implicated
Pityrosporum ovale after he observed it
in the scales. However, this yeast is
also present as a commensal in normal
skin, and interest dwindled when it was
determined that seborrhoeic eczema
responds to topical steroids which, if
anything, should make the putative
‘infection’ worse. Interest revived with
the introduction of ketoconazole. This
antifungal agent clears seborrhoeic
eczema, albeit temporarily,
administered orally. Furthermore, the
association with HIV/AIDS could be
related to overgrowth of P.ovale due to
immunosuppression. Nowadays
pityrosporicidal additives are included
in many shampoos and other
formulations intended for the anti-
dandruff market, common dandruff
being generally regarded as a mild
variety of seborrhoeic eczema. Often,
the diagnosis of seborrhoeic eczema
can be made visually upon presentation
because the erythema and flaking on
the scalp, eyebrows and nasolabial
folds plus dandruff deposited on the
shoulders are so embarassingly obvious.
Leading questions concerning covert
patches in the praesternum,
interscapular area, and possibly flexures
may convince the client that he or she
(seborrhoeic eczema is commoner in
men) has come to the right
establishment. Dandruff and
seborrhoeic eczema are likely to persist,
with improvement in the summer. In
the winter, the face should be
protected from dessicating winds.
Common dandruff should respond to
shampoos containing selenium, zinc
pyrithione, tar, or 2% ketoconazole in
difficult cases. The pharmacist can
improve the chances of success by
explaining the correct mode of
application, for poor technique may
account for treatment failure. Some
modern facial moisturizers incorporate
piroctone olamine or similar anti-fungal
agents which may safely be used in the
long-term control of facial seborrhoeic
eczema. Another non-steroidal anti-
seborrhoeic facial preparation contains
5% lithium succinate, but this is not
yet available on the local market. On
the face, seborrhoeic eczema must be
distinguished from rosacea which
requires appropriate treatment. In the
scalp, seborrhoeic eczema may overlap
with psoriasis which is more difficult to
treat. In other areas of the body,
dermatological referral may be
indicated to exclude ringworm,
candidiasis, erythrasma, psoriasis, or
other disorders of keratinization which
mimic seborrhoeic eczema.
Psoriasis
Psoriasis affects approximately 2-
3% of the general population.4 It is the
paradigm for chronicity in dermatology,
so much so that in Malta severe
psoriasis is listed among the diseases
which entitle patients to free treatment
on Schedule V Part 2 arrangements. The
frequency and chronicity of psoriasis
are just two of the many aspects which
make it so important in terms of
personal hardship5 and economic costs
to the community.6 The Psoriasis
Association of Malta is a useful source
of information on the local scene.7
Immunological derangements are
implicated in the aetiology of psoriasis
but the fundamental cause remains
mysterious, and so symptomatic
remedies abound.
The scientific rationale is to reduce
the rate of epidermal cell turnover
which is accelerated in the plaques and
which, in the scalp, is responsible for
the well-defined raised areas of salmon
redness and heaped-up silvery scales
which feel like a ploughed field when
running the fingers through the hair.
There is no hair loss except in an
unusual variant called Pityriasis
amiantacea which affects children and
in which asbestos-like scales (hence
the name) cling to the hair shafts.
There is a genetic predisposition to
psoriasis, and the presence of
confirmed disease in forebears is a
useful pointer to diagnosis. Other
possible important factors in the
outbreak of psoriasis are streptococcal
infections, stress, intercurrent illnesses,
operations, physical accidents, and
drugs - particularly anti-malarials and
lithium. Patients may develop tell-tale
changes in the finger nails consisting
of pits or areas where the nail plate no
longer sticks to the underlying bed
(onycholysis). These nail changes are
further clues to diagnosis. Spontaneous
remission of psoriasis is common in the
summer, and ultraviolet therapy on an
outpatient basis is a very useful
alternative for treatment of patches on
the body and which is available all the
year round. Private use of domestic
ultraviolet sources should not be
encouraged because of the risk of
sunburn in the short term and skin
cancer in the long run. Emollients are
useful OTC adjuncts in the control of
dryness, scaling and irritation. Regular
use of emollients may reduce the need
for prescription medications like topical
steroids. There are several proprietary
formulations on the market. Some are
oily and designed to be dispersed in
the bath water. Others produce a lather
and are meant to be used as substitutes
for soap. Several are oil in water
emulsions intended to be applied
directly to the skin. The pharmacist
should help the client to understand
the product clearly, thus preventing it
from being put to the wrong use. A
number of OTC emollients incorporate
Figure 2: Scalp Psoriasis (Ducray archives)
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urea and lactic acid which help the
epidermis to retain moisture. Others
contain 2% salicylic acid or 5-15%
alpha-hydroxy acids (AHAs) which help
desquamation. Tar may also be included
as an emollient ingredient. Crude tars
are chemical mixtures obtained from
the destructive distillation of organic
material. They have soothing and
keratolytic properties, which have been
exploited for the treatment of psoriasis
long before their ability to reduce
epidermal cell turnover was proven.
Crude tars stain and smell. Refinement
improves acceptibility but reduces
efficacy. Extemporaneous coal tar
formulations are still an important
standby in the hospital treatment of
psoriasis. For a very long time coal tar
has also been used in a wide variety of
proprietary OTC products including
soaps, shampoos, lotions, creams and
ointments, but its use in cosmetic
products is currently viewed with some
anxiety due to its carcinogenic
potential.8 Tar obtained from
bituminous schists (fossilized fish) is
not carcinogenic, and upmarket
“parapharmacy” products containing
them (in combination with some of the
other ingredients mentioned previously)
have recently hit the local market.
Another interesting therapeutic adjunct
which has become available locally is
the mineral salts from the Dead Sea.9
The anti-psoriatic benefits of the Dead
Sea climate have been experienced by
many European holidaymakers. The
export of these minerals from the area
is an attempt to reproduce just one of
the components of the therapeutic
regimen at home. Very severe psoriasis
may need addressing with systemic
anti-metabolites, retinoids, or immune-
modulating drugs, and dermatological
consultation is clearly imperative here.
In addition up to 10% of patients may
suffer from associated arthritic
symptoms which may require attention
by a rheumatologist. The natural
history of psoriasis is notoriously
unpredictable and isolated interludes of
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spontaneous remission may be
interspersed with frustrating episodes
of relapse.
Conclusion
Scaliness of the scalp is a relatively
common complaint. It can be a
nuisance, especially if associated with
embarrassing pruritus. There are many
possible causes, and specialist
consultation may occasionally be
required to put the problem in its
proper perspective. As explained, a
scaly scalp may be part of a more
widespread dermatosis, which requires a
holistic approach to management. This
article focused upon those relatively
common situations where a community
pharmacist could play an important role
in providing primary care or in
instigating medical referral. Spatial
constraints imposed a thumbnail sketch
approach. Hopefully the reader will be
stimulated to fill in some of the details
by looking up the references provided
below.
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Errata corrige
The Editorial Board apologizes for the following two errors which inadvertently appeared in the article entitled
“The Concept of Social Pharmacy” published in the Summer 2003 issue of the Chronic*ill:
p.12:  The email address of Prof. EW Sørensen should read ‘ews@dfh.dk’ instead of ‘ews@dfk.dk’
p.15:  Column 4 of Row 3, Table I (Dominating Method) should read ‘Qualitative’ instead of ‘Quantitative’
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